Trial Outcomes & Findings for mPCST for BMT Patients (NCT NCT01984671)

NCT ID: NCT01984671

Last Updated: 2025-10-28

Results Overview

Presented as the (total number of completed sessions for all participants) divided by the (total number of planned sessions for all participants) multiplied by 100. The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

36 participants

Primary outcome timeframe

10 weeks

Results posted on

2025-10-28

Participant Flow

Participant milestones

Participant milestones
Measure
Mobile Pain Coping Skills Training (mPCST)
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Overall Study
STARTED
18
18
Overall Study
COMPLETED
16
17
Overall Study
NOT COMPLETED
2
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

mPCST for BMT Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mobile Pain Coping Skills Training (mPCST)
n=18 Participants
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
n=18 Participants
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Total
n=36 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
n=5 Participants
13 Participants
n=7 Participants
26 Participants
n=5 Participants
Age, Categorical
>=65 years
5 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
Age, Continuous
54.6 years
n=5 Participants
57.9 years
n=7 Participants
56.25 years
n=5 Participants
Sex: Female, Male
Female
11 Participants
n=5 Participants
7 Participants
n=7 Participants
18 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
11 Participants
n=7 Participants
18 Participants
n=5 Participants
Region of Enrollment
United States
18 Participants
n=5 Participants
18 Participants
n=7 Participants
36 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 10 weeks

Population: Usual care participants did not attend sessions.

Presented as the (total number of completed sessions for all participants) divided by the (total number of planned sessions for all participants) multiplied by 100. The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

Outcome measures

Outcome measures
Measure
Mobile Pain Coping Skills Training (mPCST)
n=108 mPCST sessions
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Feasibility as Measured by the Overall Percentage of Completed Sessions
83 percentage of sessions

PRIMARY outcome

Timeframe: 10 weeks

Population: Usual care participants did not attend sessions.

The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

Outcome measures

Outcome measures
Measure
Mobile Pain Coping Skills Training (mPCST)
n=18 Participants
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Acceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment
Helpful (reported in assessment)
80 percentage of participants
Acceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment
Easy to understand (reported in assessment)
100 percentage of participants
Acceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment
Acceptable (reported in assessment)
100 percentage of participants

SECONDARY outcome

Timeframe: Baseline to 10 weeks

A positive value indicates improvement in pain disability and a negative value indicates a decline.

Outcome measures

Outcome measures
Measure
Mobile Pain Coping Skills Training (mPCST)
n=18 Participants
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
n=18 Participants
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Cohen's D Effect Size of the Change in Pain Disability From Baseline to 10 Weeks
0.79 Cohen's d
0.69 Cohen's d

SECONDARY outcome

Timeframe: Baseline to 10 weeks

A positive value indicates improvement in pain self-efficacy and a negative value indicates a decline.

Outcome measures

Outcome measures
Measure
Mobile Pain Coping Skills Training (mPCST)
n=18 Participants
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
n=18 Participants
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Cohen's D Effect Size of the Change in Pain Self-efficacy From Baseline to 10 Weeks
0.61 Cohen's d
0.10 Cohen's d

SECONDARY outcome

Timeframe: Baseline to 10 weeks

A positive value indicates improvement in pain self-efficacy and a negative value indicates a decline.

Outcome measures

Outcome measures
Measure
Mobile Pain Coping Skills Training (mPCST)
n=18 Participants
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
n=18 Participants
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Cohen's D Effect Size of the Change in Fatigue From Baseline to 10 Weeks
0.94 Cohen's d
0.81 Cohen's d

SECONDARY outcome

Timeframe: Baseline to 10 weeks

A positive value indicates improvement in the 2-minute walk test and a negative value indicates a decline.

Outcome measures

Outcome measures
Measure
Mobile Pain Coping Skills Training (mPCST)
n=18 Participants
Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.
Usual Care Control
n=18 Participants
Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.
Cohen's D Effect Size of the Change in 2-minute Walk Test From Baseline to 10 Weeks
0.66 Cohen's d
0.41 Cohen's d

Adverse Events

Mobile Pain Coping Skills Training (mPCST)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Tamara Somers, PhD

Duke University School of Medicine

Phone: 919-416-3408

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place